Asahi Kasei Stock News

TOKYO--(BUSINESS WIRE)--Asahi Kasei and P2H2 have signed an MOU to evaluate manufacturing scale-up and commercialization of water electrolysis systems using AEM technology.

TOKYO--(BUSINESS WIRE)--Asahi Kasei Therapeutics, Inc., the global specialty pharmaceutical business of Tokyo-based Asahi Kasei, with U.S. and European business headquarters in Cary, North Carolina, today announced that the U.S. Food and Drug Administration (FDA) has approved HOVILPRI® (pritelivir) 100 mg tablets for the treatment of mucocutaneous lesions caused by herpes simplex virus (HSV) in...

The US FDA on Friday approved Japan's Asahi Kasei's drug for persistent herpes simplex virus ​sores in certain patients with weakened immune systems ‌who have not responded to available antiviral treatments.

TOKYO--(BUSINESS WIRE)--Asahi Kasei Microdevices held a ceremony to celebrate the recognition of the 1983 commercialization of thin-film Hall elements as an IEEE Milestone.

TOKYO--(BUSINESS WIRE)--Asahi Kasei Therapeutics announced that the first patient has been dosed in a randomized Phase 2a clinical trial (NCT07503561) evaluating AIC468.

TOKYO--(BUSINESS WIRE)--Asahi Kasei Therapeutics, Veloxis Pharmaceuticals, Calliditas Therapeutics, and AiCuris will come together under the Asahi Kasei Therapeutics brand.

GLENVIEW, Ill.--(BUSINESS WIRE)--Asahi Kasei Bioprocess will unveil the VANTIJ® SU-VFC Benchtop at Bioprocess International East (BPI EAST) 2026.

TOKYO--(BUSINESS WIRE)--Asahi Kasei Microdevices has announced that its CZ39 and CZ3K series have been adopted as in Microchip Technology's ML/AI-based AFD reference design.